ARMO BioSciences, Inc. IPO Research Information

ARMO BioSciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on ARMO BioSciences, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
ARMO BioSciences, Inc.	ARMO - NASDAQ	$14.00-$16.00	$17.00	$28.00	7.5 million	1/26/2018
Underwriter(s): Jefferies, Leerink, BMO Capital Markets
Co-Manager(s): Baird
Industry: Health Care
Filing(s): Filed 2017-12-29 Terms Added 2018-01-16 Final Prospectus 2018-01-29

ARMO BioSciences, Inc. Quote & Chart - Click for current quote - ARMO

About ARMO BioSciences, Inc. (adapted from ARMO BioSciences, Inc. prospectus):
They are a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates that activate the immune system of cancer patients to recognize and eradicate tumors.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ARMO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.